West Pharmaceutical Services, Inc. has announced the election of Janet Haugen to its board of directors, bringing the total number of directors to 12. Ms. Haugen, 66, previously served as the chief financial officer of Unisys Corporation for over 16 years and has extensive experience in finance, technology, and corporate development.
During her tenure at Unisys, she oversaw the company's transformation from a mainframe hardware, software, and maintenance company to an IT services and software provider. Ms. Haugen also brings expertise from her time as a partner at Ernst & Young, where she worked with Fortune 500 companies in the technology and manufacturing industries.
Ms. Haugen currently serves on the boards of directors of Bentley Systems, Juniper Networks, and CentralSquare Technologies. She holds a degree in economics from Rutgers University and is a certified director of the National Association of Corporate Directors.
Paolo Pucci, lead independent director at West, expressed the company's pleasure in welcoming Ms. Haugen to the board. He highlighted her unique combination of technology and finance expertise and emphasized her potential to enhance the company's impact in delivering healthcare to millions of patients daily.
West Pharmaceutical Services, Inc. is a global leader in innovative solutions for injectable drug administration, with approximately 10,000 team members across 50 sites worldwide. In fiscal year 2023, the company generated $2.95 billion in net sales. West is traded on the New York Stock Exchange under the ticker symbol WST and is included in the S&P 500 index. Following these announcements, the company's shares moved -0.3%, and are now trading at a price of $318.22. Check out the company's full 8-K submission here.
